サマリー

強迫性障害治療薬の世界市場 2024-2028
強迫性障害治療薬市場は2023-2028年に3億4854万米ドルで成長し、予測期間中のCAGRは5.93%で加速すると予測されます。当レポートでは、強迫性障害治療薬市場の全体的な分析、市場規模および予測、動向、成長促進要因、課題、さらに約25のベンダーを網羅したベンダー分析などを掲載しています。
現在の市場シナリオ、最新動向と促進要因、全体的な市場環境に関する最新分析を提供しています。強迫性障害の有病率の上昇、新薬の上市、強迫性障害の啓発プログラムの増加などが市場を牽引しています。
Technavio社の強迫性障害治療薬市場は以下のようにセグメント化されています：
製品別
- SSRI
- TSA
- その他
投与経路別
- 経口
- 経口
地域別
- 北米
- ヨーロッパ
- アジア
- その他の地域（ROW）
本調査では、今後数年間の強迫性障害治療薬市場の成長を促進する主な理由の1つとして、適応外治療の使用の増加を挙げています。また、ファーストインクラスのペプチド治療薬に関する研究の拡大やジェネリック医薬品の承認の増加は、市場の大きな需要につながるでしょう。
本レポートでは、強迫性障害治療薬市場について以下の領域をカバーしています：
- 強迫性障害治療薬市場のサイジング
- 強迫性障害治療薬市場予測
- 強迫性障害治療薬市場産業分析
強固なベンダー分析は、クライアントが市場での地位を向上させるために設計されており、これに沿って、本レポートは、Alembic Pharmaceuticals Ltd.を含むいくつかの主要な強迫性障害治療薬市場のベンダーの詳細な分析を提供しています、Anant Pharmaceuticals Pvt. Ltd., Apotex Inc., BrainsWay Ltd., Dellwich Healthcare LLP, Eli Lilly and Co., Eridanus, flamingopharma.com, GlaxoSmithKline Plc, H Lundbeck AS, Jabs Biotech, Jazz Pharmaceuticals Plc, Kabir Lifesciences, Lepu Medical Technology Beijing Co.Ltd.、Lifecare Neuro Products Ltd.、Novartis AG、Omeros Corp.、Pfizer Inc.、SERVOMAX Ltd.、Wellona Pharma、Neurocon Inc.また、強迫性障害治療薬市場分析レポートには、市場成長に影響を与える今後の動向と課題に関する情報も含まれています。これは、企業が戦略を立て、来るべき成長機会をすべて活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/obsessive-compulsive-disorder-drugs-market-industry-analysis をご覧ください。
当出版社では、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数の情報源からのデータを調査、統合、総括する方法で、市場の詳細なイメージを提示しています。また、主要な業界インフルエンサーを特定することで、市場の様々な側面を提示しています。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた綿密なベンダー選定方法と分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Product
o Exhibit 06: Executive Summary - Chart on Market Segmentation by Route of Administration
o Exhibit 07: Executive Summary - Chart on Incremental Growth
o Exhibit 08: Executive Summary - Data Table on Incremental Growth
o Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2023
o 3.4 Market outlook: Forecast for 2023-2028
o Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
o Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
• 4 Historic Market Size
o 4.1 Global obsessive-compulsive disorder drugs market 2018 - 2022
o Exhibit 18: Historic Market Size - Data Table on global obsessive-compulsive disorder drugs market 2018 - 2022 ($ million)
o 4.2 Product Segment Analysis 2018 - 2022
o Exhibit 19: Historic Market Size - Product Segment 2018 - 2022 ($ million)
o 4.3 Route of Administration Segment Analysis 2018 - 2022
o Exhibit 20: Historic Market Size - Route of Administration Segment 2018 - 2022 ($ million)
o 4.4 Geography Segment Analysis 2018 - 2022
o Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
o 4.5 Country Segment Analysis 2018 - 2022
o Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
o 5.7 Market condition
o Exhibit 29: Chart on Market condition - Five forces 2023 and 2028
• 6 Market Segmentation by Product
o 6.1 Market segments
o Exhibit 30: Chart on Product - Market share 2023-2028 (%)
o Exhibit 31: Data Table on Product - Market share 2023-2028 (%)
o 6.2 Comparison by Product
o Exhibit 32: Chart on Comparison by Product
o Exhibit 33: Data Table on Comparison by Product
o 6.3 SSRI - Market size and forecast 2023-2028
o Exhibit 34: Chart on SSRI - Market size and forecast 2023-2028 ($ million)
o Exhibit 35: Data Table on SSRI - Market size and forecast 2023-2028 ($ million)
o Exhibit 36: Chart on SSRI - Year-over-year growth 2023-2028 (%)
o Exhibit 37: Data Table on SSRI - Year-over-year growth 2023-2028 (%)
o 6.4 TSA - Market size and forecast 2023-2028
o Exhibit 38: Chart on TSA - Market size and forecast 2023-2028 ($ million)
o Exhibit 39: Data Table on TSA - Market size and forecast 2023-2028 ($ million)
o Exhibit 40: Chart on TSA - Year-over-year growth 2023-2028 (%)
o Exhibit 41: Data Table on TSA - Year-over-year growth 2023-2028 (%)
o 6.5 Others - Market size and forecast 2023-2028
o Exhibit 42: Chart on Others - Market size and forecast 2023-2028 ($ million)
o Exhibit 43: Data Table on Others - Market size and forecast 2023-2028 ($ million)
o Exhibit 44: Chart on Others - Year-over-year growth 2023-2028 (%)
o Exhibit 45: Data Table on Others - Year-over-year growth 2023-2028 (%)
o 6.6 Market opportunity by Product
o Exhibit 46: Market opportunity by Product ($ million)
o Exhibit 47: Data Table on Market opportunity by Product ($ million)
• 7 Market Segmentation by Route of Administration
o 7.1 Market segments
o Exhibit 48: Chart on Route of Administration - Market share 2023-2028 (%)
o Exhibit 49: Data Table on Route of Administration - Market share 2023-2028 (%)
o 7.2 Comparison by Route of Administration
o Exhibit 50: Chart on Comparison by Route of Administration
o Exhibit 51: Data Table on Comparison by Route of Administration
o 7.3 Oral - Market size and forecast 2023-2028
o Exhibit 52: Chart on Oral - Market size and forecast 2023-2028 ($ million)
o Exhibit 53: Data Table on Oral - Market size and forecast 2023-2028 ($ million)
o Exhibit 54: Chart on Oral - Year-over-year growth 2023-2028 (%)
o Exhibit 55: Data Table on Oral - Year-over-year growth 2023-2028 (%)
o 7.4 Parentral - Market size and forecast 2023-2028
o Exhibit 56: Chart on Parentral - Market size and forecast 2023-2028 ($ million)
o Exhibit 57: Data Table on Parentral - Market size and forecast 2023-2028 ($ million)
o Exhibit 58: Chart on Parentral - Year-over-year growth 2023-2028 (%)
o Exhibit 59: Data Table on Parentral - Year-over-year growth 2023-2028 (%)
o 7.5 Market opportunity by Route of Administration
o Exhibit 60: Market opportunity by Route of Administration ($ million)
o Exhibit 61: Data Table on Market opportunity by Route of Administration ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 63: Chart on Market share By Geographical Landscape 2023-2028 (%)
o Exhibit 64: Data Table on Market share By Geographical Landscape 2023-2028 (%)
o 9.2 Geographic comparison
o Exhibit 65: Chart on Geographic comparison
o Exhibit 66: Data Table on Geographic comparison
o 9.3 North America - Market size and forecast 2023-2028
o Exhibit 67: Chart on North America - Market size and forecast 2023-2028 ($ million)
o Exhibit 68: Data Table on North America - Market size and forecast 2023-2028 ($ million)
o Exhibit 69: Chart on North America - Year-over-year growth 2023-2028 (%)
o Exhibit 70: Data Table on North America - Year-over-year growth 2023-2028 (%)
o 9.4 Europe - Market size and forecast 2023-2028
o Exhibit 71: Chart on Europe - Market size and forecast 2023-2028 ($ million)
o Exhibit 72: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
o Exhibit 73: Chart on Europe - Year-over-year growth 2023-2028 (%)
o Exhibit 74: Data Table on Europe - Year-over-year growth 2023-2028 (%)
o 9.5 Asia - Market size and forecast 2023-2028
o Exhibit 75: Chart on Asia - Market size and forecast 2023-2028 ($ million)
o Exhibit 76: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
o Exhibit 77: Chart on Asia - Year-over-year growth 2023-2028 (%)
o Exhibit 78: Data Table on Asia - Year-over-year growth 2023-2028 (%)
o 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
o Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
o Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
o Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
o Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
o 9.7 US - Market size and forecast 2023-2028
o Exhibit 83: Chart on US - Market size and forecast 2023-2028 ($ million)
o Exhibit 84: Data Table on US - Market size and forecast 2023-2028 ($ million)
o Exhibit 85: Chart on US - Year-over-year growth 2023-2028 (%)
o Exhibit 86: Data Table on US - Year-over-year growth 2023-2028 (%)
o 9.8 Germany - Market size and forecast 2023-2028
o Exhibit 87: Chart on Germany - Market size and forecast 2023-2028 ($ million)
o Exhibit 88: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
o Exhibit 89: Chart on Germany - Year-over-year growth 2023-2028 (%)
o Exhibit 90: Data Table on Germany - Year-over-year growth 2023-2028 (%)
o 9.9 China - Market size and forecast 2023-2028
o Exhibit 91: Chart on China - Market size and forecast 2023-2028 ($ million)
o Exhibit 92: Data Table on China - Market size and forecast 2023-2028 ($ million)
o Exhibit 93: Chart on China - Year-over-year growth 2023-2028 (%)
o Exhibit 94: Data Table on China - Year-over-year growth 2023-2028 (%)
o 9.10 France - Market size and forecast 2023-2028
o Exhibit 95: Chart on France - Market size and forecast 2023-2028 ($ million)
o Exhibit 96: Data Table on France - Market size and forecast 2023-2028 ($ million)
o Exhibit 97: Chart on France - Year-over-year growth 2023-2028 (%)
o Exhibit 98: Data Table on France - Year-over-year growth 2023-2028 (%)
o 9.11 Japan - Market size and forecast 2023-2028
o Exhibit 99: Chart on Japan - Market size and forecast 2023-2028 ($ million)
o Exhibit 100: Data Table on Japan - Market size and forecast 2023-2028 ($ million)
o Exhibit 101: Chart on Japan - Year-over-year growth 2023-2028 (%)
o Exhibit 102: Data Table on Japan - Year-over-year growth 2023-2028 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 103: Market opportunity By Geographical Landscape ($ million)
o Exhibit 104: Data Tables on Market opportunity By Geographical Landscape ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 105: Impact of drivers and challenges in 2023 and 2028
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 107: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 108: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 109: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 110: Matrix on vendor position and classification
o 12.3 Anant Pharmaceuticals Pvt. Ltd.
o Exhibit 111: Anant Pharmaceuticals Pvt. Ltd. - Overview
o Exhibit 112: Anant Pharmaceuticals Pvt. Ltd. - Product / Service
o Exhibit 113: Anant Pharmaceuticals Pvt. Ltd. - Key offerings
o 12.4 Apotex Inc.
o Exhibit 114: Apotex Inc. - Overview
o Exhibit 115: Apotex Inc. - Product / Service
o Exhibit 116: Apotex Inc. - Key offerings
o 12.5 BrainsWay Ltd.
o Exhibit 117: BrainsWay Ltd. - Overview
o Exhibit 118: BrainsWay Ltd. - Product / Service
o Exhibit 119: BrainsWay Ltd. - Key offerings
o 12.6 Eli Lilly and Co.
o Exhibit 120: Eli Lilly and Co. - Overview
o Exhibit 121: Eli Lilly and Co. - Product / Service
o Exhibit 122: Eli Lilly and Co. - Key news
o Exhibit 123: Eli Lilly and Co. - Key offerings
o 12.7 Eridanus
o Exhibit 124: Eridanus - Overview
o Exhibit 125: Eridanus - Product / Service
o Exhibit 126: Eridanus - Key offerings
o 12.8 flamingopharma.com
o Exhibit 127: flamingopharma.com - Overview
o Exhibit 128: flamingopharma.com - Product / Service
o Exhibit 129: flamingopharma.com - Key offerings
o 12.9 GlaxoSmithKline Plc
o Exhibit 130: GlaxoSmithKline Plc - Overview
o Exhibit 131: GlaxoSmithKline Plc - Business segments
o Exhibit 132: GlaxoSmithKline Plc - Key news
o Exhibit 133: GlaxoSmithKline Plc - Key offerings
o Exhibit 134: GlaxoSmithKline Plc - Segment focus
o 12.10 H Lundbeck AS
o Exhibit 135: H Lundbeck AS - Overview
o Exhibit 136: H Lundbeck AS - Product / Service
o Exhibit 137: H Lundbeck AS - Key offerings
o 12.11 Jazz Pharmaceuticals Plc
o Exhibit 138: Jazz Pharmaceuticals Plc - Overview
o Exhibit 139: Jazz Pharmaceuticals Plc - Product / Service
o Exhibit 140: Jazz Pharmaceuticals Plc - Key news
o Exhibit 141: Jazz Pharmaceuticals Plc - Key offerings
o 12.12 Lepu Medical Technology Beijing Co. Ltd.
o Exhibit 142: Lepu Medical Technology Beijing Co. Ltd. - Overview
o Exhibit 143: Lepu Medical Technology Beijing Co. Ltd. - Product / Service
o Exhibit 144: Lepu Medical Technology Beijing Co. Ltd. - Key offerings
o 12.13 Lifecare Neuro Products Ltd.
o Exhibit 145: Lifecare Neuro Products Ltd. - Overview
o Exhibit 146: Lifecare Neuro Products Ltd. - Key offerings
o 12.14 Neurocon Inc.
o Exhibit 147: Neurocon Inc. - Overview
o Exhibit 148: Neurocon Inc. - Product / Service
o Exhibit 149: Neurocon Inc. - Key offerings
o 12.15 Novartis AG
o Exhibit 150: Novartis AG - Overview
o Exhibit 151: Novartis AG - Business segments
o Exhibit 152: Novartis AG - Key offerings
o Exhibit 153: Novartis AG - Segment focus
o 12.16 Pfizer Inc.
o Exhibit 154: Pfizer Inc. - Overview
o Exhibit 155: Pfizer Inc. - Product / Service
o Exhibit 156: Pfizer Inc. - Key news
o Exhibit 157: Pfizer Inc. - Key offerings
o 12.17 Wellona Pharma
o Exhibit 158: Wellona Pharma - Overview
o Exhibit 159: Wellona Pharma - Product / Service
o Exhibit 160: Wellona Pharma - Key offerings
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 161: Inclusions checklist
o Exhibit 162: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 163: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 164: Research methodology
o Exhibit 165: Validation techniques employed for market sizing
o Exhibit 166: Information sources
o 13.5 List of abbreviations
o Exhibit 167: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Product
Exhibits6: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits18: Historic Market Size - Data Table on global obsessive-compulsive disorder drugs market 2018 - 2022 ($ million)
Exhibits19: Historic Market Size - Product Segment 2018 - 2022 ($ million)
Exhibits20: Historic Market Size - Route of Administration Segment 2018 - 2022 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
Exhibits23: Five forces analysis - Comparison between 2023 and 2028
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits29: Chart on Market condition - Five forces 2023 and 2028
Exhibits30: Chart on Product - Market share 2023-2028 (%)
Exhibits31: Data Table on Product - Market share 2023-2028 (%)
Exhibits32: Chart on Comparison by Product
Exhibits33: Data Table on Comparison by Product
Exhibits34: Chart on SSRI - Market size and forecast 2023-2028 ($ million)
Exhibits35: Data Table on SSRI - Market size and forecast 2023-2028 ($ million)
Exhibits36: Chart on SSRI - Year-over-year growth 2023-2028 (%)
Exhibits37: Data Table on SSRI - Year-over-year growth 2023-2028 (%)
Exhibits38: Chart on TSA - Market size and forecast 2023-2028 ($ million)
Exhibits39: Data Table on TSA - Market size and forecast 2023-2028 ($ million)
Exhibits40: Chart on TSA - Year-over-year growth 2023-2028 (%)
Exhibits41: Data Table on TSA - Year-over-year growth 2023-2028 (%)
Exhibits42: Chart on Others - Market size and forecast 2023-2028 ($ million)
Exhibits43: Data Table on Others - Market size and forecast 2023-2028 ($ million)
Exhibits44: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibits45: Data Table on Others - Year-over-year growth 2023-2028 (%)
Exhibits46: Market opportunity by Product ($ million)
Exhibits47: Data Table on Market opportunity by Product ($ million)
Exhibits48: Chart on Route of Administration - Market share 2023-2028 (%)
Exhibits49: Data Table on Route of Administration - Market share 2023-2028 (%)
Exhibits50: Chart on Comparison by Route of Administration
Exhibits51: Data Table on Comparison by Route of Administration
Exhibits52: Chart on Oral - Market size and forecast 2023-2028 ($ million)
Exhibits53: Data Table on Oral - Market size and forecast 2023-2028 ($ million)
Exhibits54: Chart on Oral - Year-over-year growth 2023-2028 (%)
Exhibits55: Data Table on Oral - Year-over-year growth 2023-2028 (%)
Exhibits56: Chart on Parentral - Market size and forecast 2023-2028 ($ million)
Exhibits57: Data Table on Parentral - Market size and forecast 2023-2028 ($ million)
Exhibits58: Chart on Parentral - Year-over-year growth 2023-2028 (%)
Exhibits59: Data Table on Parentral - Year-over-year growth 2023-2028 (%)
Exhibits60: Market opportunity by Route of Administration ($ million)
Exhibits61: Data Table on Market opportunity by Route of Administration ($ million)
Exhibits62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits63: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits64: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits65: Chart on Geographic comparison
Exhibits66: Data Table on Geographic comparison
Exhibits67: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibits68: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibits69: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits70: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits71: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits72: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits73: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits74: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits75: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits76: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits77: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits78: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits83: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibits84: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibits85: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits86: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits87: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits88: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits89: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits90: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits91: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibits92: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibits93: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits94: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits95: Chart on France - Market size and forecast 2023-2028 ($ million)
Exhibits96: Data Table on France - Market size and forecast 2023-2028 ($ million)
Exhibits97: Chart on France - Year-over-year growth 2023-2028 (%)
Exhibits98: Data Table on France - Year-over-year growth 2023-2028 (%)
Exhibits99: Chart on Japan - Market size and forecast 2023-2028 ($ million)
Exhibits100: Data Table on Japan - Market size and forecast 2023-2028 ($ million)
Exhibits101: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibits102: Data Table on Japan - Year-over-year growth 2023-2028 (%)
Exhibits103: Market opportunity By Geographical Landscape ($ million)
Exhibits104: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits105: Impact of drivers and challenges in 2023 and 2028
Exhibits106: Overview on Criticality of inputs and Factors of differentiation
Exhibits107: Overview on factors of disruption
Exhibits108: Impact of key risks on business
Exhibits109: Vendors covered
Exhibits110: Matrix on vendor position and classification
Exhibits111: Anant Pharmaceuticals Pvt. Ltd. - Overview
Exhibits112: Anant Pharmaceuticals Pvt. Ltd. - Product / Service
Exhibits113: Anant Pharmaceuticals Pvt. Ltd. - Key offerings
Exhibits114: Apotex Inc. - Overview
Exhibits115: Apotex Inc. - Product / Service
Exhibits116: Apotex Inc. - Key offerings
Exhibits117: BrainsWay Ltd. - Overview
Exhibits118: BrainsWay Ltd. - Product / Service
Exhibits119: BrainsWay Ltd. - Key offerings
Exhibits120: Eli Lilly and Co. - Overview
Exhibits121: Eli Lilly and Co. - Product / Service
Exhibits122: Eli Lilly and Co. - Key news
Exhibits123: Eli Lilly and Co. - Key offerings
Exhibits124: Eridanus - Overview
Exhibits125: Eridanus - Product / Service
Exhibits126: Eridanus - Key offerings
Exhibits127: flamingopharma.com - Overview
Exhibits128: flamingopharma.com - Product / Service
Exhibits129: flamingopharma.com - Key offerings
Exhibits130: GlaxoSmithKline Plc - Overview
Exhibits131: GlaxoSmithKline Plc - Business segments
Exhibits132: GlaxoSmithKline Plc - Key news
Exhibits133: GlaxoSmithKline Plc - Key offerings
Exhibits134: GlaxoSmithKline Plc - Segment focus
Exhibits135: H Lundbeck AS - Overview
Exhibits136: H Lundbeck AS - Product / Service
Exhibits137: H Lundbeck AS - Key offerings
Exhibits138: Jazz Pharmaceuticals Plc - Overview
Exhibits139: Jazz Pharmaceuticals Plc - Product / Service
Exhibits140: Jazz Pharmaceuticals Plc - Key news
Exhibits141: Jazz Pharmaceuticals Plc - Key offerings
Exhibits142: Lepu Medical Technology Beijing Co. Ltd. - Overview
Exhibits143: Lepu Medical Technology Beijing Co. Ltd. - Product / Service
Exhibits144: Lepu Medical Technology Beijing Co. Ltd. - Key offerings
Exhibits145: Lifecare Neuro Products Ltd. - Overview
Exhibits146: Lifecare Neuro Products Ltd. - Key offerings
Exhibits147: Neurocon Inc. - Overview
Exhibits148: Neurocon Inc. - Product / Service
Exhibits149: Neurocon Inc. - Key offerings
Exhibits150: Novartis AG - Overview
Exhibits151: Novartis AG - Business segments
Exhibits152: Novartis AG - Key offerings
Exhibits153: Novartis AG - Segment focus
Exhibits154: Pfizer Inc. - Overview
Exhibits155: Pfizer Inc. - Product / Service
Exhibits156: Pfizer Inc. - Key news
Exhibits157: Pfizer Inc. - Key offerings
Exhibits158: Wellona Pharma - Overview
Exhibits159: Wellona Pharma - Product / Service
Exhibits160: Wellona Pharma - Key offerings
Exhibits161: Inclusions checklist
Exhibits162: Exclusions checklist
Exhibits163: Currency conversion rates for US$
Exhibits164: Research methodology
Exhibits165: Validation techniques employed for market sizing
Exhibits166: Information sources
Exhibits167: List of abbreviations